Bronwyn M. Gunn, Ph.D. - Publications

Affiliations: 
2013 Microbiology & Immunology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Virology Biology, Immunology

31/66 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Fox JM, Roy V, Gunn BM, Bolton GR, Fremont DH, Alter G, Diamond MS, Boesch AW. Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography. Frontiers in Immunology. 14: 1153108. PMID 37251375 DOI: 10.3389/fimmu.2023.1153108  0.324
2023 Bukreyev A, Ilinykh P, Huang K, Gunn B, Kuzmina N, Gilchuk P, Alter G, Crowe J. Antiviral protection by antibodies targeting the glycan cap of Ebola virus glycoprotein requires activation of the complement system. Research Square. PMID 37131834 DOI: 10.21203/rs.3.rs-2765936/v1  0.308
2022 Seifert SN, Bai S, Fawcett S, Norton EB, Zwezdaryk KJ, Robinson J, Gunn B, Letko M. An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines. Plos Pathogens. 18: e1010828. PMID 36136995 DOI: 10.1371/journal.ppat.1010828  0.306
2020 Ilinykh PA, Huang K, Santos RI, Gilchuk P, Gunn BM, Karim MM, Liang J, Fouch ME, Davidson E, Parekh DV, Kimble JB, Pietzsch CA, Meyer M, Kuzmina NA, Zeitlin L, et al. Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies. Cell Host & Microbe. PMID 32320678 DOI: 10.1016/J.Chom.2020.03.025  0.341
2019 Gunn BM, Roy V, Karim MM, Hartnett JN, Suscovich TJ, Goba A, Momoh M, Sandi JD, Kanneh L, Andersen KG, Shaffer JG, Schieffelin JS, Garry RF, Grant DS, Alter G. Survivors of Ebola virus disease develop polyfunctional antibody responses. The Journal of Infectious Diseases. PMID 31301137 DOI: 10.1093/Infdis/Jiz364  0.342
2019 Fox JM, Roy V, Gunn BM, Huang L, Edeling MA, Mack M, Fremont DH, Doranz BJ, Johnson S, Alter G, Diamond MS. Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes. Science Immunology. 4. PMID 30796092 DOI: 10.1126/Sciimmunol.Aav5062  0.407
2019 Bornholdt ZA, Herbert AS, Mire CE, He S, Cross RW, Wec AZ, Abelson DM, Geisbert JB, James RM, Rahim MN, Zhu W, Borisevich V, Banadyga L, Gunn BM, Agans KN, et al. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates. Cell Host & Microbe. 25: 49-58.e5. PMID 30629918 DOI: 10.1016/J.Chom.2018.12.005  0.372
2019 Wec AZ, Bornholdt ZA, He S, Herbert AS, Goodwin E, Wirchnianski AS, Gunn BM, Zhang Z, Zhu W, Liu G, Abelson DM, Moyer CL, Jangra RK, James RM, Bakken RR, et al. Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection. Cell Host & Microbe. 25: 39-48.e5. PMID 30629917 DOI: 10.1016/J.Chom.2018.12.004  0.317
2018 Saphire EO, Schendel SL, Gunn BM, Milligan JC, Alter G. Antibody-mediated protection against Ebola virus. Nature Immunology. 19: 1169-1178. PMID 30333617 DOI: 10.1038/S41590-018-0233-9  0.334
2018 Ilinykh PA, Santos RI, Gunn BM, Kuzmina NA, Shen X, Huang K, Gilchuk P, Flyak AI, Younan P, Alter G, Crowe JE, Bukreyev A. Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. Plos Pathogens. 14: e1007204. PMID 30138408 DOI: 10.1371/Journal.Ppat.1007204  0.335
2018 Gunn BM, Yu WH, Karim MM, Brannan JM, Herbert AS, Wec AZ, Halfmann PJ, Fusco ML, Schendel SL, Gangavarapu K, Krause T, Qiu X, He S, Das J, Suscovich TJ, et al. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. Cell Host & Microbe. 24: 221-233.e5. PMID 30092199 DOI: 10.1016/J.Chom.2018.07.009  0.32
2018 Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, Davidson E, Doranz BJ, Turner HL, Fusco ML, Bramble MS, Hoff NA, Binshtein E, Kose N, Flyak AI, et al. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity. PMID 30029854 DOI: 10.1016/J.Immuni.2018.06.018  0.311
2018 Luke T, Bennett RS, Gerhardt DM, Burdette T, Postnikova E, Mazur S, Honko AN, Oberlander N, Byrum R, Ragland D, St Claire M, Janosko KB, Smith G, Glenn G, Hooper J, ... ... Gunn B, et al. Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate. The Journal of Infectious Diseases. PMID 30010950 DOI: 10.1093/Infdis/Jiy377  0.377
2018 Gunn BM, Jones JE, Shabman RS, Whitmore AC, Sarkar S, Blevins LK, Morrison TE, Heise MT. Ross River virus envelope glycans contribute to disease through activation of the host complement system. Virology. 515: 250-260. PMID 29324290 DOI: 10.1016/J.Virol.2017.12.022  0.622
2014 Stoermer Burrack KA, Hawman DW, Jupille HJ, Oko L, Minor M, Shives KD, Gunn BM, Long KM, Morrison TE. Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection. Journal of Virology. 88: 3719-32. PMID 24429363 DOI: 10.1128/Jvi.02609-13  0.468
2013 Long KM, Whitmore AC, Ferris MT, Sempowski GD, McGee C, Trollinger B, Gunn B, Heise MT. Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice. Journal of Virology. 87: 5697-706. PMID 23487448 DOI: 10.1128/Jvi.01611-12  0.663
2012 Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, Fraser RJ, Herrero LJ, Ramirez R, Smith PN, Mahalingam S, Heise MT. Mannose binding lectin is required for alphavirus-induced arthritis/myositis. Plos Pathogens. 8: e1002586. PMID 22457620 DOI: 10.1371/Journal.Ppat.1002586  0.669
2011 Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, Elmore SA, Heise MT. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. The American Journal of Pathology. 178: 32-40. PMID 21224040 DOI: 10.1016/J.Ajpath.2010.11.018  0.655
2011 Jupille HJ, Oko L, Stoermer KA, Heise MT, Mahalingam S, Gunn BM, Morrison TE. Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model. Virology. 410: 216-27. PMID 21131014 DOI: 10.1016/J.Virol.2010.11.012  0.599
2010 Wang S, Li Y, Scarpellini G, Kong W, Shi H, Baek CH, Gunn B, Wanda SY, Roland KL, Zhang X, Senechal-Willis P, Curtiss R. Salmonella Vaccine Vectors Displaying Delayed Antigen Synthesis In Vivo To Enhance Immunogenicity Infection and Immunity. 78: 3969-3980. PMID 20605977 DOI: 10.1128/Iai.00444-10  0.396
2010 Curtiss R, Xin W, Li Y, Kong W, Wanda SY, Gunn B, Wang S. New technologies in using recombinant attenuated Salmonella vaccine vectors. Critical Reviews in Immunology. 30: 255-270. PMID 20370633 DOI: 10.1615/Critrevimmunol.V30.I3.30  0.378
2010 Torres-Escobar A, Juárez-Rodríguez MD, Gunn BM, Branger CG, Tinge SA, Curtiss R. Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice. Infection and Immunity. 78: 2529-43. PMID 20308296 DOI: 10.1128/Iai.00005-10  0.39
2010 Gunn BM, Wanda SY, Burshell D, Wang C, Curtiss R. Construction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice. Clinical and Vaccine Immunology : Cvi. 17: 354-62. PMID 20053874 DOI: 10.1128/Cvi.00412-09  0.406
2010 Shi H, Wang S, Roland KL, Gunn BM, Curtiss R. Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers. Clinical and Vaccine Immunology : Cvi. 17: 363-71. PMID 20053873 DOI: 10.1128/Cvi.00413-09  0.417
2009 Hall JD, Kurtz SL, Rigel NW, Gunn BM, Taft-Benz S, Morrison JP, Fong AM, Patel DD, Braunstein M, Kawula TH. The impact of chemokine receptor CX3CR1 deficiency during respiratory infections with Mycobacterium tuberculosis or Francisella tularensis. Clinical and Experimental Immunology. 156: 278-84. PMID 19250281 DOI: 10.1111/J.1365-2249.2009.03882.X  0.458
2009 Li Y, Wang S, Scarpellini G, Gunn B, Xin W, Wanda SY, Roland KL, Curtiss R. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA Proceedings of the National Academy of Sciences of the United States of America. 106: 593-598. PMID 19114649 DOI: 10.1073/Pnas.0811697106  0.419
2009 Curtiss R, Wanda SY, Gunn BM, Zhang X, Tinge SA, Ananthnarayan V, Mo H, Wang S, Kong W. Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo. Infection and Immunity. 77: 1071-82. PMID 19103774 DOI: 10.1128/Iai.00693-08  0.454
2008 Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infection and Immunity. 76: 5843-52. PMID 18852251 DOI: 10.1128/Iai.01176-08  0.443
2008 Frandsen JL, Gunn B, Muratoglu S, Fossett N, Newfeld SJ. Salmonella pathogenesis reveals that BMP signaling regulates blood cell homeostasis and immune responses in Drosophila. Proceedings of the National Academy of Sciences of the United States of America. 105: 14952-7. PMID 18815369 DOI: 10.1073/Pnas.0808208105  0.339
2008 Li Y, Wang S, Xin W, Scarpellini G, Shi Z, Gunn B, Roland KL, Curtiss R. A sopB Deletion Mutation Enhances the Immunogenicity and Protective Efficacy of a Heterologous Antigen Delivered by Live Attenuated Salmonella enterica Vaccines Infection and Immunity. 76: 5238-5246. PMID 18765737 DOI: 10.1128/Iai.00720-08  0.459
2008 Bollen WS, Gunn BM, Mo H, Lay MK, Curtiss R. Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infection and Immunity. 76: 3268-72. PMID 18474649 DOI: 10.1128/Iai.00244-08  0.426
Low-probability matches (unlikely to be authored by this person)
2016 Gunn BM, Schneider JR, Shansab M, Bastian AR, Fahrbach KM, Smith AD, Mahan AE, Karim MM, Licht AF, Zvonar I, Tedesco J, Anderson MR, Chapel A, Suscovich TJ, Malaspina DC, et al. Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16. Mucosal Immunology. PMID 26960182 DOI: 10.1038/Mi.2016.8  0.299
2016 Barnett BE, Staupe RP, Odorizzi PM, Palko O, Tomov VT, Mahan AE, Gunn B, Chen D, Paley MA, Alter G, Reiner SL, Lauer GM, Teijaro JR, Wherry EJ. Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 27430722 DOI: 10.4049/Jimmunol.1500368  0.286
2015 Holtsberg FW, Shulenin S, Vu H, Howell KA, Patel SJ, Gunn B, Karim M, Lai JR, Frei JC, Nyakatura EK, Zeitlin L, Douglas R, Fusco ML, Froude JW, Saphire EO, et al. Pan-ebolavirus and pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses. Journal of Virology. PMID 26468533 DOI: 10.1128/Jvi.02171-15  0.283
2020 Malherbe DC, Domi A, Hauser MJ, Meyer M, Gunn BM, Alter G, Bukreyev A, Guirakhoo F. Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. Npj Vaccines. 5: 78. PMID 34471139 DOI: 10.1038/s41541-020-00226-y  0.282
2020 Malherbe DC, Domi A, Hauser MJ, Meyer M, Gunn BM, Alter G, Bukreyev A, Guirakhoo F. Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. Npj Vaccines. 5: 78. PMID 32922962 DOI: 10.1038/s41541-020-00226-y  0.282
2021 Gunn BM, Bai S. Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection. Human Vaccines & Immunotherapeutics. 1-17. PMID 34613865 DOI: 10.1080/21645515.2021.1976580  0.277
2018 Kimble JB, Malherbe DC, Meyer M, Gunn BM, Karim MM, Ilinykh PA, Iampietro M, Mohamed KS, Negi S, Gilchuk P, Huang K, Wolf YI, Braun W, Crowe JE, Alter G, et al. ANTIBODY-MEDIATED PROTECTIVE MECHANISMS INDUCED BY A TRIVALENT PARAINFLUENZA-VECTORED EBOLAVIRUS VACCINE. Journal of Virology. PMID 30518655 DOI: 10.1128/Jvi.01845-18  0.274
2018 Saphire EO, Schendel SL, Fusco ML, Gangavarapu K, Gunn BM, Wec AZ, Halfmann PJ, Brannan JM, Herbert AS, Qiu X, Wagh K, He S, Giorgi EE, Theiler J, Pommert KBJ, et al. Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell. 174: 938-952.e13. PMID 30096313 DOI: 10.1016/J.Cell.2018.07.033  0.273
2021 Paquin-Proulx D, Gunn BM, Alrubayyi A, Clark DV, Creegan M, Kim D, Kibuuka H, Millard M, Wakabi S, Eller LA, Michael NL, Schoepp RJ, Hepburn MJ, Hensley LE, Robb ML, et al. Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors. Frontiers in Immunology. 12: 682120. PMID 34093585 DOI: 10.3389/fimmu.2021.682120  0.267
2016 Gunn BM, Alter G. Modulating Antibody Functionality in Infectious Disease and Vaccination. Trends in Molecular Medicine. PMID 27756530 DOI: 10.1016/J.Molmed.2016.09.002  0.264
2023 Gunn BM, McNamara RP, Wood L, Taylor S, Devadhasan A, Guo W, Das J, Nilsson A, Shurtleff A, Dubey S, Eichberg M, Suscovich TJ, Saphire EO, Lauffenburger D, Coller BA, et al. Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates. Cell Reports. 42: 112402. PMID 37061918 DOI: 10.1016/j.celrep.2023.112402  0.256
2022 Grace PS, Gunn BM, Lu LL. Engineering the supernatural: monoclonal antibodies for challenging infectious diseases. Current Opinion in Biotechnology. 78: 102818. PMID 36242952 DOI: 10.1016/j.copbio.2022.102818  0.253
2020 Rappazzo CG, Tse LV, Kaku CI, Wrapp D, Sakharkar M, Huang D, Deveau LM, Yockachonis TJ, Herbert AS, Battles MB, O'Brien CM, Brown ME, Geoghegan JC, Belk J, Peng L, ... ... Gunn BM, et al. An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19. Biorxiv : the Preprint Server For Biology. PMID 33236009 DOI: 10.1101/2020.11.17.385500  0.252
2023 Lauritsen CJ, Trinh IV, Desai SP, Clancey E, Murrell AE, Rambaran S, Chandra S, Elliott DH, Smira AR, Mo Z, Stone AE, Agbodji A, Dugas CM, Satou R, Pridjian G, ... ... Gunn BM, et al. Passive antibody transfer from pregnant women to their fetus are maximized after SARS-CoV-2 vaccination irrespective of prior infection. The Journal of Allergy and Clinical Immunology. Global. 3: 100189. PMID 38268538 DOI: 10.1016/j.jacig.2023.100189  0.249
2021 Gunn BM, Lu R, Slein MD, Ilinykh PA, Huang K, Atyeo C, Schendel SL, Kim J, Cain C, Roy V, Suscovich TJ, Takada A, Halfmann PJ, Kawaoka Y, Pauthner MG, et al. A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus. Immunity. 54: 815-828.e5. PMID 33852832 DOI: 10.1016/j.immuni.2021.03.009  0.242
2017 Francica JR, Zak DE, Linde C, Siena E, Johnson C, Juraska M, Yates NL, Gunn B, De Gregorio E, Flynn BJ, Valiante NM, Malyala P, Barnett SW, Sarkar P, Singh M, et al. Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs. Blood Advances. 1: 2329-2342. PMID 29296883 DOI: 10.1182/Bloodadvances.2017011411  0.24
2021 Jin C, Hill J, Gunn BM, Yu WH, Dahora LC, Jones E, Johnson M, Gibani MM, Spreng RL, Alam SM, Nebykova A, Juel HB, Dennison SM, Seaton KE, Fallon JK, et al. Vi-specific serological correlates of protection for typhoid fever. The Journal of Experimental Medicine. 218. PMID 33180929 DOI: 10.1084/jem.20201116  0.236
2009 Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang DZ. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. The Journal of Clinical Investigation. 119: 2772-86. PMID 19726871 DOI: 10.1172/Jci36154  0.233
2020 Gilchuk P, Murin CD, Milligan JC, Cross RW, Mire CE, Ilinykh PA, Huang K, Kuzmina N, Altman PX, Hui S, Gunn BM, Bryan AL, Davidson E, Doranz BJ, Turner HL, et al. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization. Immunity. PMID 32023489 DOI: 10.1016/J.Immuni.2020.01.001  0.231
2021 Rappazzo CG, Tse LV, Kaku CI, Wrapp D, Sakharkar M, Huang D, Deveau LM, Yockachonis TJ, Herbert AS, Battles MB, O'Brien CM, Brown ME, Geoghegan JC, Belk J, Peng L, ... ... Gunn BM, et al. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science (New York, N.Y.). PMID 33495307 DOI: 10.1126/science.abf4830  0.231
2018 King LB, Fusco ML, Flyak AI, Ilinykh PA, Huang K, Gunn B, Kirchdoerfer RN, Hastie KM, Sangha AK, Meiler J, Alter G, Bukreyev A, Crowe JE, Saphire EO. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. Cell Host & Microbe. 23: 101-109.e4. PMID 29324225 DOI: 10.1016/J.Chom.2017.12.003  0.219
2021 Ngere I, Dawa J, Hunsperger E, Otieno N, Masika M, Amoth P, Makayotto L, Nasimiyu C, Gunn BM, Nyawanda B, Oluga O, Ngunu C, Mirieri H, Gachohi J, Marwanga D, et al. sssHigh seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya. International Journal of Infectious Diseases : Ijid : Official Publication of the International Society For Infectious Diseases. PMID 34481966 DOI: 10.1016/j.ijid.2021.08.062  0.218
2021 Gilchuk P, Guthals A, Bonissone SR, Shaw JB, Ilinykh PA, Huang K, Bombardi RG, Liang J, Grinyo A, Davidson E, Chen EC, Gunn BM, Alter G, Saphire EO, Doranz BJ, et al. Proteo-Genomic Analysis Identifies Two Major Sites of Vulnerability on Ebolavirus Glycoprotein for Neutralizing Antibodies in Convalescent Human Plasma. Frontiers in Immunology. 12: 706757. PMID 34335620 DOI: 10.3389/fimmu.2021.706757  0.218
2023 Schmidt P, Narayan K, Li Y, Kaku CI, Brown ME, Champney E, Geoghegan JC, Vásquez M, Krauland EM, Yockachonis T, Bai S, Gunn BM, Cammarata A, Rubino CM, Ambrose P, et al. Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Science Translational Medicine. 15: eadg2783. PMID 36947596 DOI: 10.1126/scitranslmed.adg2783  0.216
2021 Meyer M, Gunn BM, Malherbe DC, Gangavarapu K, Yoshida A, Pietzsch C, Kuzmina NA, Saphire EO, Collins PL, Crowe JE, Zhu JJ, Suchard MA, Brining DL, Mire CE, Cross RW, et al. Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effects. Science Translational Medicine. 13. PMID 34261800 DOI: 10.1126/scitranslmed.abg6128  0.214
2022 Schmidt P, Narayan K, Li Y, Kaku C, Brown M, Champney E, Geoghegan J, Vasquez M, Krauland E, Yockachonis T, Bai S, Gunn B, Cammarata A, Rubino C, Walker LM. Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Medrxiv : the Preprint Server For Health Sciences. PMID 36299436 DOI: 10.1101/2022.10.18.22281172  0.203
2022 Murin CD, Gunn BM, Parren PWHI, Kobinger GP. Editorial: Antibody Therapeutics for the Treatment of Filoviral Infection. Frontiers in Immunology. 13: 859919. PMID 35251051 DOI: 10.3389/fimmu.2022.859919  0.198
2022 Gunn BM. Holding it together: Nanoparticle stabilization of LASV trimer. Cell Host & Microbe. 30: 1660-1661. PMID 36521442 DOI: 10.1016/j.chom.2022.11.009  0.188
2021 Tokuyama M, Gunn BM, Venkataraman A, Kong Y, Kang I, Rakib T, Townsend MJ, Costenbader KH, Alter G, Iwasaki A. Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus. The Journal of Experimental Medicine. 218. PMID 34019642 DOI: 10.1084/jem.20191766  0.175
2018 Yu WH, Zhao P, Draghi M, Arevalo C, Karsten CB, Suscovich TJ, Gunn B, Streeck H, Brass AL, Tiemeyer M, Seaman M, Mascola JR, Wells L, Lauffenburger DA, Alter G. Exploiting glycan topography for computational design of Env glycoprotein antigenicity. Plos Computational Biology. 14: e1006093. PMID 29677181 DOI: 10.1371/Journal.Pcbi.1006093  0.173
2023 Lu S, Chen K, Song K, Pilewski JM, Gunn BM, Poch KR, Rysavy NM, Vestal BE, Saavedra MT, Kolls JK. Systems serology in cystic fibrosis: Anti-Pseudomonas IgG1 responses and reduced lung function. Cell Reports. Medicine. 4: 101210. PMID 37852181 DOI: 10.1016/j.xcrm.2023.101210  0.163
2018 Bricault CA, Kovacs JM, Badamchi-Zadeh A, McKee K, Shields JL, Gunn BM, Neubauer GH, Ghantous F, Jennings J, Gillis L, Perry J, Nkolola JP, Alter G, Chen B, Stephenson KE, et al. Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs. Journal of Virology. PMID 29643249 DOI: 10.1128/Jvi.00369-18  0.162
2020 Masoudzadeh N, Östensson M, Persson J, Mashayekhi Goyonlo V, Agbajogu C, Taslimi Y, Erfanian Salim R, Zahedifard F, Mizbani A, Malekafzali Ardekani H, Gunn BM, Rafati S, Harandi AM. Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica. Scientific Reports. 10: 16198. PMID 33004861 DOI: 10.1038/s41598-020-72671-7  0.135
2020 Njenga MK, Dawa J, Nanyingi M, Gachohi J, Ngere I, Letko M, Otieno CF, Gunn BM, Osoro E. Why is There Low Morbidity and Mortality of COVID-19 in Africa? The American Journal of Tropical Medicine and Hygiene. PMID 32484156 DOI: 10.4269/ajtmh.20-0474  0.098
2008 Bradley J, Gunn B, Skira I, Meathrel C, Wooller R. Age-dependent prospecting and recruitment to a breeding colony of Short-tailed Shearwaters Puffinus tenuirostris Ibis. 141: 277-285. DOI: 10.1111/j.1474-919X.1999.tb07550.x  0.029
Hide low-probability matches.